Private company
AVEO PHARMACEUTICALS, INC.
Last updated Oct 16, 2026.
Overview
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2021
-117.2%Operating margin3
-126.1%Net margin3
602.7%Revenue growth, 20213
-116.3%Return on equity3
-$57.3MFree cash flow3
Where the money goes
Where each dollar of revenue went, fiscal 2021
- Cost of revenue5¢$4.7M
- Research and development29¢$26.3M
- Selling, general and admin66¢$60.8M
Out of $42.3M in revenue.3 The company lost money this year.
Financial statements
No quarterly figures reported.
| Fiscal year | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|
| Revenue | $19.0M4 | $2.5M5 | $7.6M6 | $5.4M7 | $28.8M3 | $6.0M3 | $42.3M3 |
| Cost of revenue | $03 | $03 | $4.7M3 | ||||
| Research and development | $12.9M4 | $23.7M5 | $25.2M6 | $20.7M7 | $18.0M3 | $22.7M3 | $26.3M3 |
| Selling, general and admin | $10.8M7 | $11.2M3 | $22.2M3 | $60.8M3 | |||
| Operating income | -$12.4M4 | -$29.4M5 | -$28.8M6 | -$25.4M7 | -$374.0K3 | -$38.9M3 | -$49.6M3 |
| Interest | $2.3M4 | $1.9M5 | $2.4M6 | $2.2M7 | $1.8M7 | $1.6M7 | |
| Income tax | $101.0K5 | $101.0K6 | $06 | $07 | $03 | $03 | |
| Net income | -$15.0M4 | -$26.9M5 | -$65.0M6 | -$5.3M7 | $9.4M3 | -$35.6M3 | -$53.3M3 |
| Earnings per share | -$0.395 | -$6.146 | -$0.447 | $0.613 | -$1.663 | -$1.633 | |
| Earnings per share (diluted) | -$0.395 | -$6.146 | -$1.937 | $0.613 | -$1.663 | -$1.633 |
No quarterly figures reported.
| Fiscal year | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|
| Cash | $26.6M5 | $15.1M5 | $14.9M5 | $24.4M6 | $29.8M7 | $61.8M3 | $70.5M3 |
| Current assets | $40.4M8 | $26.3M4 | $50.2M5 | $27.9M6 | $50.6M7 | $65.5M3 | $104.7M3 |
| Total assets | $40.5M8 | $27.3M4 | $50.2M5 | $27.9M6 | $50.6M7 | $66.9M3 | $105.3M3 |
| Current liabilities | $12.4M8 | $10.3M4 | $32.1M5 | $18.1M6 | $21.1M7 | $16.9M3 | $18.7M3 |
| Long-term debt | $10.0M9 | $16.2M6 | |||||
| Total liabilities | $23.3M8 | $29.2M4 | $91.0M5 | $55.2M6 | $35.8M7 | $31.6M3 | $59.5M3 |
| Shareholders’ equity | $17.2M5 | -$1.9M6 | -$40.8M7 | -$27.2M3 | $14.8M3 | $35.3M3 | $45.9M3 |
| Shares outstanding | 58.2M shares8 | 75.9M shares4 | 118.3M shares5 | 12.6M shares6 | 16.1M shares7 | 26.9M shares3 | 34.5M shares3 |
Former names
- AVEO PHARMACEUTICALS INCApr 27, 2005 to Apr 23, 20202
Recent filings
- Jan 19, 20238-K
- Jan 19, 20234 FORM 4 SUBMISSION
- Jan 19, 20234 FORM 4 SUBMISSION
- Jan 19, 20234 FORM 4 SUBMISSION
- Jan 19, 20234 FORM 4 SUBMISSION
- Jan 19, 20234 FORM 4 SUBMISSION
- Jan 19, 20234 FORM 4 SUBMISSION
- Jan 19, 20234 FORM 4 SUBMISSION
- Jan 19, 20234 FORM 4 SUBMISSION
- Jan 19, 20234 FORM 4 SUBMISSION
- Jan 19, 20234 FORM 4 SUBMISSION
- Jan 18, 20238-K
- Jan 5, 20238-K
- Dec 22, 20224
- Dec 2, 20228-K
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9